{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:40:42Z","timestamp":1762609242867,"version":"3.41.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Breast cancer diagnosis had been linked to an increased risk of melanoma in several reports. The aim of the current study was to assess the role of genetics, increased surveillance, and radiation treatment in patients with a dual diagnosis of breast cancer and melanoma (DBM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>All patients treated at Sheba Medical Center between 2007 and 2021 with DBM were included in the cohort. Data on family history, genetic tests, characteristics, and treatment of both cancers were collected. The proportion of patients with a pathogenic variant (PV) in <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> and <jats:italic toggle=\"yes\">BRCA2<\/jats:italic> genes was compared to a control group of patients with breast cancer. The proportion of patients presenting with in-situ disease was compared to the national registry data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The cohort included 222 DBM patients of whom 114 had documentation of genetic testing. Twenty patients tested positive for PVs of which 13 (11%) were in BRCA genes. This was comparable to the proportion in patients with a diagnosis of breast cancer (736; 19%). The proportion of melanoma diagnosed at stage 0 was comparable to the national proportion (<jats:italic toggle=\"yes\">N<\/jats:italic>\u2009=\u200940; 30% vs. 28%, respectively). In comparison to the national registry, a larger proportion of breast cancers were ductal carcinoma in situ or lobular carcinoma in situ [10% in the registry vs. 19% (22) in the cohort; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.003].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In patients with DBM we did not find an increased proportion of PVs in BRCA genes. Our findings suggest that the increased standardized incidence ratio of the dual diagnosis may be partially explained by increased surveillance and detection of earlier-stage cancers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000792","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T10:12:13Z","timestamp":1678702333000},"page":"418-422","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Characterization of patients with a diagnosis of breast cancer and melanoma: genetic susceptibility or increased surveillance?"],"prefix":"10.1097","volume":"32","author":[{"given":"Karen Y.","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Surgery, Maimonides Medical Center, Brooklyn, New York, USA"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tehillah S.","family":"Menes","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"},{"name":"Department of General and Oncological Surgery-Surgery C, Chaim Sheba Medical Center, Tel Hashomer"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinat","family":"Bernstein-Molho","sequence":"additional","affiliation":[{"name":"Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviram","family":"Nissan","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"},{"name":"Department of General and Oncological Surgery-Surgery C, Chaim Sheba Medical Center, Tel Hashomer"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dov","family":"Zippel","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv"},{"name":"Department of General and Oncological Surgery-Surgery C, Chaim Sheba Medical Center, Tel Hashomer"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10549-020-05633-2","article-title":"Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants.","volume":"181","author":"Bernstein-Molho","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1002\/cncr.33560","article-title":"Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population.","volume":"127","author":"Bernstein-Molho","year":"2021","journal-title":"Cancer"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.bjc.6605435","article-title":"Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.","volume":"102","author":"Berrington de Gonzalez","year":"2010","journal-title":"Br J Cancer"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","article-title":"Differences in cancer phenotypes among frequent CHEK2 variants and implications for clinical care-checking CHEK2.","volume":"8","author":"Bychkovsky","year":"2022","journal-title":"JAMA Oncol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jdv.13645","article-title":"Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52,354 cancer patients in Northern Italy.","volume":"9","author":"Caini","year":"2016","journal-title":"J Eur Acad Dermatol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/IGC.0b013e3181b9f5d5","article-title":"Distribution of second primary malignancies suggests a bidrectional effect between breast and endometrial cancer: a population-based study.","volume":"19","author":"Cortesi","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/jech.2007.063560","article-title":"New malignancies among cancer survivors: SEER Cancer Registries, 1973\u20132000.","volume":"62","author":"Curtis","year":"2008","journal-title":"J Epidemiol Community Health"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes \u2013 association analysis in more than 113,000 women.","volume":"384","author":"Dorling","year":"2021","journal-title":"N Engl J Med"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/annonc\/mdg169","article-title":"Cancer prevalence in the UK: results from the EUROPREVAL study.","volume":"1","author":"Forman","year":"2003","journal-title":"Ann Oncol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ijc.20322","article-title":"Association between female breast cancer and cutaneous melanoma.","volume":"111","author":"Goggins","year":"2004","journal-title":"Int J Cancer"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"102989","DOI":"10.1016\/j.critrevonc.2020.102989","article-title":"The Melanoma and Breast Cancer Association: an overview of their \u2018second primary cancers\u2019 and the epidemiological, genetic and biological correlations.","volume":"152","author":"Jeyakumar","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.21.02112","article-title":"Cancer risks associated with BRCA1 and BRCA2 pathogenic variants.","volume":"40","author":"Li","year":"2022","journal-title":"J Clin Oncol"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bjc.6605148","article-title":"Cancer prevalence in the United Kingdom: estimates for 2008.","volume":"101","author":"Maddams","year":"2009","journal-title":"Br J Cancer"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/ijc.21651","article-title":"Risk of second cancer among women with breast cancer.","volume":"118","author":"Mellemkjaer","year":"2006","journal-title":"Int J Cancer"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2014.10.029","article-title":"Risk of second cancers, cancer after a first primary breast cancer: a systematic review and meta-analysis.","volume":"136","author":"Molina-Montes","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society.","volume":"314","author":"Oeffinger","year":"2015","journal-title":"JAMA"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002.","volume":"55","author":"Parkin","year":"2005","journal-title":"Cancer J Clin"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.","volume":"14","author":"Roa","year":"1996","journal-title":"Nat Genet"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1006489918700","article-title":"Increased risk of second cancers following breast cancer: role of the initial treatment.","volume":"61","author":"Rubino","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2007.11.9081","article-title":"Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.","volume":"26","author":"Schaapveld","year":"2008","journal-title":"J Clin Oncol"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JGO.2016.003699","article-title":"Second primary cancers after primary breast cancer diagnosis in Israeli women, 1992 to 2006.","volume":"3","author":"Silverman","year":"2016","journal-title":"J Glob Oncol"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-005-4016-2","article-title":"Primary malignancy after primary female breast cancer in the South of the Netherlands.","volume":"93","author":"Soerjomataram","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1158\/1055-9965.EPI-06-0414","article-title":"The epidemiology of second primary cancers.","volume":"15","author":"Travis","year":"2006","journal-title":"Cancer Epidemiol Biomarkers"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1023\/A:1018487506546","article-title":"Second primary cancers in breast cancer patients in Slovenia.","volume":"8","author":"Volk","year":"1997","journal-title":"Cancer Causes Control"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:04:21Z","timestamp":1748361861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000792","relation":{},"ISSN":["0959-8278"],"issn-type":[{"type":"print","value":"0959-8278"}],"subject":[],"published":{"date-parts":[[2023,3,13]]}}}